Αποτελέσματα Αναζήτησης
19 Ιουλ 2023 · According to the guidelines, pediatricians should offer weight loss drugs to adolescents ages 12 and up with obesity, alongside diet and lifestyle changes that encourage healthy eating and...
In this episode of the Children’s Health Checkup podcast, a pediatric endocrinologist dives into the sensitive topic of weight loss treatment for children, including weight loss medication and bariatric surgery, addressing common concerns while providing a balanced view of the available options.
The U.S. Food and Drug Administration has approved Saxenda (liraglutide) for chronic weight management among patients aged 12 and older who are obese, as defined by specific body mass index (BMI)...
11 Ιαν 2023 · Daily injectable liraglutide (brand name Saxenda) is FDA approved for obesity management in children 12 years or older. In June 2022, the FDA approved a supplemental indication for phentermine...
The U.S. Food and Drug Administration (FDA) has approved four weight management medications for children ages 12 and older: orlistat (Xenical), 2 liraglutide (Saxenda), 3 phentermine-topiramate (Qsymia), 4 and semaglutide (Wegovy). 5,6 A fifth prescription medication, setmelanotide (IMCIVREE), 7 is approved by the FDA for children ages 6 years ...
1 Μαρ 2021 · Metformin was the most commonly prescribed medication across all ages, including off-label use for weight-loss among children and adolescents. The most commonly off-label prescribed AOM among YA was topiramate.
9 Ιαν 2023 · Jan 9 (Reuters) - The American Academy of Pediatrics (AAP) on Monday recommended use of weight-loss drugs in children ages 12 years or older for treatment of obesity, which impacts about 14.4...
